The diagnosis of esophageal cancer by 2-deoxy-2-F-18 fluoro-D-glucose positron emission tomography (F-18 FDG PET)

Mohab Alexander, James Robert Brašić

Research output: Contribution to journalArticlepeer-review

Abstract

FDG PET plays an essential role in the diagnosis and treatment of patients with esophageal carcinoma. A 67-year-old man, who presented with dysphagia, fatigue, weakness, anorexia, anergia, and weight loss, underwent Tc-99m bone scan, CT, and FDG PET imaging. The bone scan and CT were consistent with a malignancy. Whole-body FDG PET demonstrated multiple metastases in various locations and helped the treating physicians to institute appropriate therapy. The identification of metastases by FDG PET is a critical component of the initial evaluation of a patient with esophageal carcinoma for the diagnosis and treatment of the primary malignancy and metastases.

Original languageEnglish (US)
Pages (from-to)566-567
Number of pages2
JournalClinical nuclear medicine
Volume31
Issue number9
DOIs
StatePublished - Sep 1 2006

Keywords

  • Carcinoma
  • Dysphagia
  • Esophagus
  • Malignancy
  • Metastases
  • Radiation therapy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'The diagnosis of esophageal cancer by 2-deoxy-2-F-18 fluoro-D-glucose positron emission tomography (F-18 FDG PET)'. Together they form a unique fingerprint.

Cite this